ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 95 filers reported holding ODONATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $74,000 | -45.2% | 54,472 | +17.5% | 0.00% | – |
Q3 2021 | $135,000 | -16.1% | 46,344 | +0.3% | 0.00% | – |
Q2 2021 | $161,000 | -75.0% | 46,228 | -75.4% | 0.00% | – |
Q1 2021 | $643,000 | -82.7% | 187,876 | -3.0% | 0.00% | -100.0% |
Q4 2020 | $3,718,000 | +68.8% | 193,662 | +18.0% | 0.00% | – |
Q3 2020 | $2,203,000 | -68.8% | 164,077 | -1.5% | 0.00% | -100.0% |
Q2 2020 | $7,056,000 | +89.5% | 166,644 | +23.6% | 0.00% | +100.0% |
Q1 2020 | $3,724,000 | -26.0% | 134,873 | -13.1% | 0.00% | 0.0% |
Q4 2019 | $5,035,000 | +21.2% | 155,151 | -2.8% | 0.00% | 0.0% |
Q3 2019 | $4,156,000 | +5.6% | 159,699 | +48.8% | 0.00% | 0.0% |
Q2 2019 | $3,937,000 | +71.2% | 107,289 | +3.2% | 0.00% | 0.0% |
Q1 2019 | $2,299,000 | +78.4% | 103,984 | +13.6% | 0.00% | – |
Q4 2018 | $1,289,000 | -19.4% | 91,550 | +11.1% | 0.00% | – |
Q3 2018 | $1,600,000 | -2.7% | 82,425 | +10.6% | 0.00% | – |
Q2 2018 | $1,645,000 | +10.5% | 74,510 | +6.0% | 0.00% | – |
Q1 2018 | $1,489,000 | – | 70,306 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $297,880,000 | 45.48% |
Boxer Capital, LLC | 5,607,086 | $107,656,000 | 3.46% |
Samsara BioCapital, LLC | 815,421 | $15,656,000 | 1.57% |
GSA CAPITAL PARTNERS LLP | 148,148 | $2,844,000 | 0.46% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,211,728 | $23,265,000 | 0.38% |
RTW INVESTMENTS, LP | 1,000,139 | $19,203,000 | 0.32% |
Sio Capital Management, LLC | 75,500 | $1,450,000 | 0.30% |
AlphaCentric Advisors LLC | 29,594 | $568,000 | 0.24% |
Birchview Capital, LP | 20,000 | $384,000 | 0.22% |
Aristides Capital LLC | 33,226 | $638,000 | 0.22% |